$ALMU

Aeluma Announces Fourth Quarter and Full Fiscal Year 2026 Financial Results

Aeluma, Inc. (ALMU) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Aeluma Announces Fourth Quarter and Full Fiscal Year 2026 Financial Results Signed CHIPS Letter of Intent for up to $30 Million for AI and Advanced Computing Executed New Strategic Agreement With Sumitomo Chemical Advanced Technologies to Expand Relationship and Incr

Original reporting
Published Sep 16, 2026, 8:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 8:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ALMU
Bearish
medium confidence
Mentioned
$ALMU
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ALMUBearishMed
01

Why it matters

The earnings release shows a widening loss but a significant cash raise and potential federal funding, creating a mixed short‑term outlook.

02

Market read

Micro‑cap earnings with modest scale; primary relevance to traders with exposure to AI photonics niche.

03

What to watch

The $30M CHIPS LOI is not yet guaranteed; execution risk remains high for a micro‑cap.

Relevance 7/10Novelty 7/10Timing: post‑filing Sep 16 2026

Background

Aeluma is a small NASDAQ‑listed semiconductor company focusing on photonics for AI and advanced computing.

Company-level read

Ticker impact

$ALMUBearishMedium confidence
Context

Aeluma filed its 8‑K reporting Q4 and FY 2026 results, revealing $0.6M Q4 revenue, a $4.0M net loss and a $20.1M cash raise.

Expected impact

Potential short‑term downside as investors digest loss and dilution; upside if market values new CHIPS funding.

Evidence & confidence

Losses are larger than prior year and revenue is down, but the $20.1M capital infusion and CHIPS LOI could support future growth.

Market effects

Highlights ongoing government support for AI photonics, may benefit peers in semiconductor photonics.

US semiconductor sector could see modest interest; no immediate broader market effect.

Limited to niche AI photonics niche; not a macro driver.

Counterpoint

Despite the loss, the CHIPS funding and expanded capacity could position Aeluma for outsized upside if AI datacom demand accelerates.

Key entities

  • Jonathan Klamkin

    Provided commentary on AI datacom opportunity and CHIPS funding.

  • Department of Commerce CHIPS R&D Office

    Potential $30M funding source via LOI.

Related articles

$ALMUMed

Aeluma (ALMU) Q4 2026 Earnings Call Transcript

Aeluma (ALMU) reported Q4 2026 revenue of $582,000 and a GAAP net loss of $4 million, or $0.22 per share. Full-year revenue was $4.5 million, down from $4.7 million in 2025. The company is shifting focus to the AI datacom market, investing in manufacturing and hiring, with $56 million in cash reserves. It expects $2.3 million in government revenue for 2027 and is pursuing additional contracts and partnerships.

High

Why is Aeluma stock surging today?

Aeluma stock rose 7.0% in pre-market trading after announcing a partnership with Sumitomo Chemical Advanced Technologies to develop and manufacture photonics wafers for AI datacom. The company is set to report Q4 and full-year 2026 earnings on September 16. The sole analyst's price target of $30.50 suggests significant upside from current levels.

$ALMUMed

The Speed of Light: 5 Stocks Powering AI’s Optical Future

MarketBeat highlights NVIDIA’s broader photonics investment and says the global photonics market is about $1.25T, growing mid-single digits through the next decade, with silicon photonics rising ~30% annually. It profiles Aeluma (NASDAQ: ALMU), citing quantum-dot lasers and a manufacturing method that grows optical-quality substrate on silicon. The article notes Aeluma is pre-revenue, seeks data-center/defense partnerships for design wins and prototype certifications, and targets production and

$ALMUMedAI 8/10

Aeluma Sees Accelerated Timeline for Quantum Commercialization

Aeluma (NASDAQ: ALMU) said the U.S. Department of Commerce announced proposed CHIPS Act incentives of more than $2 billion for nine companies to accelerate quantum computing, shifting from R&D to manufacturing. Aeluma supported one company that signed a letter of intent, with involvement contingent on a subcontract. Aeluma cited its scalable wafer platform and recent U.S. contracts for quantum materials and lasers.

$STTMedAI 8/10

State Street Corp (STT) (Q3 2026) Earnings Call Highlights: Record AUC/A

State Street Corp (STT) reported Q3 2026 earnings, with record AUC/A of $59. Other fee revenue declined by ~$30M YoY, and FX revenue fell 14% QoQ. Loan growth slowed, but NII is expected to grow in Q4. The company plans to increase buybacks to achieve an 80% payout ratio. Management expressed confidence in medium-term targets, citing strong NII trends and organic fee growth.

$AZZHighAI 8/10

AZZ Inc (AZZ) (Q2 2027) Earnings Call Highlights: Record Sales, Raised Guidance, and a 29% EPS Jump

AZZ Inc reported Q2 2027 earnings with record sales, raised guidance, and a 29% EPS jump. The company cited strong demand in Metal Coatings and the Seattle Galvanizing acquisition's performance. Challenges include softer HVAC volume, tight steel substrate markets, and potential margin pressure from tariffs. The debt reduction target was lowered to $100-$140 million due to the acquisition.